Expert Radar
Dr. Charles Farber, MD, PhD
Dr. Charles Farber, MD, PhD
Medical Director, Atlantic Health System
Doctor of Medicine, NYU Grossman School of Medicine
Dr. Charles M. Farber has 31 years of experience in the field of Medical Oncology. He earned his BA in Chemistry from the University of Rochester, his MD from NYU Grossman School of Medicine, and his MS and PhD from New York University Graduate School of Arts and Science. He completed both his residency in Medicine and a fellowship in Hematology and Oncology at NewYork-Presbyterian/Weill Cornell Medical Center. Today, this expert is board certified in Medical Oncology. Formerly, this expert held roles as an Assistant Attending Physician at NewYork-Presbyterian Hospital and Clinical Assistant Physician at Memorial Sloan Kettering Cancer Center. He was also the Chief of the Division of Hematology and Oncology at Morristown Medical Center. Currently, he serves as the Medical Director of Cancer Research Network Development at Atlantic Health System and as an Attending Physician at Morristown Medical Center.
c*********@a*****.org
(973) ***-****
Morristown, New Jersey
Get a FREE Demo of Dr. Charles Farber, MD, PhD's Radar Profile
Review this expert's litigation history, supporting legal docs, publications, professional background, and more.
Comprehensive data on expert witnesses: Access detailed litigation history and performance metrics.
Swift assessment: Quickly evaluate an expert's track record.
Informed decisions: Make better choices when selecting or challenging expert witnesses in any case.
Radar Metrics At A Glance
Expert Witness Activity
18
Plaintiff Cases
7
Defense Cases
10
Expert Challenges
4
Deposition Transcripts
Publications
66
Media & News
212
Social Media Mentions
Expert Institute operates independently and objectively as an expert witness data provider. Expert Institute does not employ, endorse, or have an affiliation with any expert witnesses for which data is provided.
Expert Witness Activity
Radar found 27 records
Case Name | Role | Filed Date |
|---|---|---|
Ibelize Frost, as Personal Representative of the Estate of Thomas Frost v. Florida Cancer Specialists and Research Institute, LLC, et al. | Expert Witness | 2021-11-29 |
Billy F. Smith, et al. v. Access Health Care Physicians, et al. | Expert Witness | 2020-03-26 |
Maria Sokolova v. Michael Amoashiy, M.D., et al. | Expert Witness | 2019-03-15 |
Radar monitors both national and state court systems to track litigation activity and access court documents.
View case details, documents, plaintiff and defense representation, defendants, judges, jurisdiction, and more.
Litigation Analytics
Retained By
Defense
Plaintiff
Activity over time
0
25
50
75
100
2000
0
2002
0
2004
0
2006
0
2008
0
2010
0
Activity by state
Case Outcome
0
25
50
75
100
Publications
Radar found 66 records
Title | Type |
|---|---|
The Clinical and Economic Value of Rituximab for the Treatment of Hematologic Malignancies | Journal Article |
A phase I dose escalation of ublituximab (TG-1101), a novel anti-CD20 monoclonal antibody (mab) for rituximab relapsed and/or refractory B-cell lymphoma patients | Journal Article |
A phase III, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of idelalisib (GS-1101) in combination with bendamustine and rituximab for previously treated chronic lymphocytic leukemia (CLL) | Journal Article |
Radar monitors a wide array of publication sources, including links to abstracts.
Review book chapters, journal articles, research papers, trade publications, technical reports, conference proceedings, and more.
Media & News
Radar found 212 records
Title | Description |
|---|---|
Combination of Pembro and Liposomal Gemcitabine ... | Jul 9, 2024 ----- ... Clinical Oncology opens in a new tab or window (ASCO) meeting. In this exclusive MedPage Today video, Charles Farber , MD , PhD, of Atlantic ... |
Beating Metastatic Brain Cancer with Surgery and ... | After that, he began immunotherapy treatment under the care of Charles M. Farber , MD , PhD , a board-certified, fellowship-trained oncologist , which activated ... |
Waldenstrom's macroglobulinaemia refractory | Feb 21, 2024 -- Charles M Farber ; Jonah Shulman ; Emily H ... News (Medical) ... 10 Studies on InnoCare's Oncology Pipelines Selected at the Upcoming 65th Annual ... |
Radar scours thousands of media and news sources across the internet 24/7.
Access interviews, webinars, TV appearances, blog posts, columns, whitepapers, PDFs, profressional profiles, and more.
Education
Institution | Degree Type |
|---|---|
NYU Grossman School of Medicine | Doctor of Medicine |
New York University Graduate School of Arts and Science | Doctor of Philosophy |
New York University Graduate School of Arts and Science | Master of Science |
Work History
Title | Employer |
|---|---|
Medical Director | Atlantic Health System |
Chief | Morristown Medical Center |
Clinical Assistant Professor | Rutgers Robert Wood Johnson Medical School |
What to expect from a Radar profile
Access detailed litigation history and performance metrics.
Access your Radar profile through Expert iQ, our secure, cloud-based platform that hosts AI-driven insights.
Delivered in 5–7 business days
Receive your profile swiftly, with Radar gathering intelligence from thousands of data points.
24/7 monitoring for 12 months
Stay informed with continuous monitoring and live alerts, ensuring your profile is always up-to-date.
